Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 320 shares at $299.60 ($96K) on 2023-02-14, disclosed to the SEC on 2023-02-16.
Scheduled sale ($96k) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $295.89 | 71 | $21K | 22.0% |
| 2 | $296.48 | 20 | $6K | 6.2% |
| 3 | $297.98 | 43 | $13K | 13.4% |
| 4 | $299.60 | 135 | $40K | 42.3% |
| 5 | $300.58 | 51 | $15K | 16.0% |
| Total | $298.52 avg | 320 |
| $96K |
| 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |